ํจ๋ผ์กธ๋ฆฐ
ํจ๋ผ์กธ๋ฆฐ์ ๋น์ ํ์ ๊ฒฝ์์ **์ํ-์๋๋ ๋ ๋ฆฐ ์์ฉ์ฒด ์ฐจ๋จ์ **๋ก, ์์ํ์์๋ ์ฃผ๋ก ๋ง๊ณผ ๋ฐ์ถ๋๋ฌผ์์ **์์ผ๋ผ์ง(xylazine)**์ ์ง์ , ์งํต ๋ฐ ์ฌํ๊ด๊ณ ํจ๊ณผ๋ฅผ ์ญ์ ์ํค๋ ๋ฐ ์ฌ์ฉ๋ฉ๋๋ค. * **์์ ์์ **: ์์ผ๋ผ์ง ์ญ์ ์๋ ๋งค์ฐ ํจ๊ณผ์ ์ด์ง๋ง, ๋ฑ์ค๋ฉ๋ฐํ ๋ฏธ๋์ด๋ ๋ฐํ ๋ฏธ๋๊ณผ ๊ฐ์ ์๋กญ๊ณ ์ ํ์ฑ์ด ๋์ ฮฑ2-์์ฉ์ ์ ๋ํด์๋ ํน์ด์ฑ๊ณผ ํจ๊ณผ๊ฐ ๋จ์ด์ง๋ ๊ฒ์ผ๋ก ๊ฐ์ฃผ๋ฉ๋๋ค(์ด ๊ฒฝ์ฐ ์ํฐํ๋ฉ์กธ์ด ์ ํธ๋จ). * ฮฑ1 ๋ฐ ฮฑ2 ์์ฉ์ฒด๋ฅผ ๋ชจ๋ ์ฐจ๋จํ๊ณ ์ง์ ์ ์ธ ํ๊ด ํ์ฅ ํน์ฑ์ ๊ฐ์ง๊ณ ์๊ธฐ ๋๋ฌธ์ ์ฌํ๊ด๊ณ์ ๋ฏธ์น๋ ์ํฅ์ด ๋ณต์กํ๊ณ ๋๋ก๋ ์์ธกํ๊ธฐ ์ด๋ ค์ธ ์ ์์ผ๋ฏ๋ก ์ฒ์ฒํ ์ฃผ์ํด์ ํฌ์ฌํด์ผ ํฉ๋๋ค.
์์ฉ ๊ธฐ์ : Tolazoline acts as a competitive antagonist at both **ฮฑ1-** and **ฮฑ2-adrenergic receptors**. * **Central & Peripheral ฮฑ2 Blockade** โ Reverses the sedation, analgesia, and bradycardia induced by ฮฑ2-agonists (like xylazine). * **Direct Smooth Muscle Relaxation** โ Exerts a direct relaxant effect on vascular smooth muscle โ **peripheral vasodilation** โ decreases total peripheral resistance. * **Onset**: Rapid acting (usually within 5 minutes of IV administration), but has a short duration of action, meaning repeat doses may occasionally be required if re-sedation occurs.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- For reversal of xylazine effects ยท 2-4 mg/kg slow IV ; titrate to effect ยท IV ยท once ยท Slaughter withdrawal: 30 days. Not FDA-approved in the USA for use in food animals.
- For reversal of xylazine effects ยท 1-2 mg /kg IM. Give 50% of initial dose slow IV or IM and then determine if more is needed. ยท IM/IV ยท once
- For reversal of xylazine effects ยท 2-4 mg/kg slow IV ; titrate to effect ยท IV ยท once ยท Slaughter withdrawal: 30 days. Not FDA-approved in the USA for use in food animals.
- For reversal of xylazine effects ยท 1-2 mg /kg IM. Give 50% of initial dose slow IV or IM and then determine if more is needed. ยท IM/IV ยท once
- For reversal of xylazine effects ยท 4 mg/kg slow IV (4 mL/220 lb. of body weight); administration rate should approximate 1 mL/second ยท IV ยท once ยท High concentration (100 mg/mL) makes accurate dosing difficult; yohimbine or human-labeled tolazoline (25 mg/mL) may be safer alternatives. Not FDA-approved for cats.
- For reversal of xylazine effects ยท 2-4 mg/kg slow IV ; titrate to effect ยท IV ยท once ยท Slaughter withdrawal: 30 days. Not FDA-approved in the USA for use in food animals.
- For reversal of xylazine effects (Emergency) ยท 2 mg/kg IM ยท IM ยท once ยท Should not be administered IV rapidly as this can result in cardiac asystole. Effects of reversal should start to become evident about 10 minutes following IM administration.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Horses exhibiting signs of stress, debilitation, or shock
- Cardiac disease or coronary artery disease
- Sympathetic blockage
- Hypovolemia
- Cerebrovascular disease
- Known hypersensitivity to the drug
- Foals (relative contraindication; adverse reactions and fatalities reported)
์ด์๋ฐ์
- Transient tachycardia
- Peripheral vasodilation (sweating, injected mucous membranes of gingiva and conjunctiva)
- Hyperalgesia of the lips (licking, flipping of lips)
- Piloerection
- Clear lacrimal and nasal discharge
- Muscle fasciculations
- Apprehensiveness and anxiety
- Gastrointestinal hypermotility (flatulence, diarrhea, mild colic)
์ฝ๋ฌผ ์ํธ์์ฉ
- Alcohol ยท Accumulation of acetaldehyde can occur if tolazoline and alcohol are given simultaneously.
- Epinephrine ยท If large doses of tolazoline are given with epinephrine, a paradoxical drop in blood pressure can occur followed by a precipitous increase in blood pressure.
- Norepinephrine ยท If large doses of tolazoline are given with norepinephrine, a paradoxical drop in blood pressure can occur followed by a precipitous increase in blood pressure.
๋ชจ๋ํฐ๋ง
- Reversal effects (efficacy of waking up/recovery)
- Heart rate and rhythm
- Blood pressure
- Adverse effects (sweating, GI hypermotility, anxiety)
๊ณผ์ฉ๋
Overdoses can cause severe cardiovascular and gastrointestinal disturbances. * **Horses (5X overdose)**: Gastrointestinal hypermotility resulting in flatulence, defecation, mild colic, and transient diarrhea. Intraventricular conduction may be slowed (prolongation of the QRS-complex). Ventricular arrhythmias and death may occur at higher overdoses. * **Camelids (5X overdose in a llama)**: Anxiety, hyperesthesia, profuse salivation, GI tract hypermotility, diarrhea, convulsions, hypotension, and tachypnea. Successfully treated with IV diazepam, phenylephrine, IV fluids, and oxygen. * **Human Treatment Note**: Ephedrine (NOT epinephrine or norepinephrine) has been recommended to treat serious tolazoline-induced hypotension.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.